부광약품(주) · KOSPI: 003000 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩125.9B | ₩160.1B | ₩200.7B |
| Operating income | −₩37.5B | ₩1.6B | ₩14.2B |
| Net income | −₩34.4B | −₩3.5B | ₩12.4B |
| Total assets | ₩429.0B | ₩373.2B | ₩476.3B |
| Total liabilities | ₩194.8B | ₩129.0B | ₩135.4B |
| Total equity | ₩234.3B | ₩244.1B | ₩340.9B |
| Share capital | ₩36.4B | ₩36.4B | ₩51.5B |
Consolidated statements · FY2025 operating margin 7.1% · liabilities to equity 40% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 66 (current) | 삼일회계법인 | Unqualified |
| Term 65 (prior) | 안진회계법인 | Unqualified |
| Term 64 (two years prior) | 안진회계법인 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2025년 07월 28일 | OCI홀딩스주식회사 | — | 유상증자 |
| 2024년 03월 29일 | OCI홀딩스주식회사 | — | 자기주식소각 |
| 2024년 01월 05일 | OCI홀딩스주식회사 | — | 특별관계자 변동 (임원퇴임) |
| 2022년 03월 25일 | OCI홀딩스주식회사외 1인 | — | 특별관계자 변동 (임원퇴임) |
| 2022년 03월 03일 | OCI홀딩스주식회사외 3인 | — | 장외매도 외 |
| 2021년 06월 16일 | 김동연외 11인 | — | 장내매도 |
| 2021년 03월 19일 | 김동연외 11인 | — | 주식배당 |
| 2020년 03월 13일 | 김동연외 11인 | — | 주식배당 외 |
| Date | Filing | Original |
|---|---|---|
| 2026-08-31 | 출자법인회생절차및파산관련결정 | DART |
| 2026-08-28 | Large business group status disclosure | DART |
| 2026-08-26 | Decision to acquire tangible assets | DART |
| 2026-08-14 | 출자법인회생절차및파산관련신청 | DART |
| 2026-08-13 | Payment terms to suppliers and dispute mediation body | DART |
| 2026-08-13 | Half-year report (2026.06) | DART |
| 2026-07-21 | Preliminary consolidated operating results (fair disclosure) | DART |
| 2026-07-15 | Investor relations event (notice) | DART |
| 2026-06-02 | Material management matter | DART |
| 2026-06-01 | Corporate governance report | DART |
| 2026-05-29 | Large business group status disclosure | DART |
| 2026-05-14 | Quarterly report (2026.03) | DART |
| 2026-05-13 | Amended: Decision to acquire shares of another company | DART |
| 2026-04-27 | Decision to acquire shares of another company | DART |
| 2026-04-21 | Preliminary consolidated operating results (fair disclosure) | DART |
| 2026-04-15 | Investor relations event (notice) | DART |
| 2026-03-24 | Corporate value-up plan (voluntary) | DART |
| 2026-03-24 | Annual general meeting results | DART |
| 2026-03-16 | Annual report (2025.12) | DART |
| 2026-03-16 | Audit report submitted | DART |
Showing the 20 most recent of 40 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.